Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin Pharmacodynamics.

Shoji, S; Suzuki, A; Conrado, D J; Peterson, M C; Hey-Hadavi, J; McCabe, D; Rojo, R; Tammara, B K

Shoji, S; Suzuki, A; Conrado, D J; Peterson, M C; Hey-Hadavi, J; McCabe, D; Rojo, R; Tammara, B K.

Affiliation

Shoji S; Pfizer Japan Inc, Tokyo, Japan.
Suzuki A; Pfizer Japan Inc, Tokyo, Japan.
Conrado DJ; Pfizer Inc, Groton, Connecticut, USA.
Peterson MC; Pfizer Inc, Cambridge, Massachusetts, USA.
Hey-Hadavi J; Pfizer Inc, Cambridge, Massachusetts, USA.
McCabe D; Pfizer Inc, New York, New York, USA.
Rojo R; Pfizer Inc, Groton, Connecticut, USA.
Tammara BK; Pfizer Inc, Collegeville, Pennsylvania, USA.

CPT Pharmacometrics Syst Pharmacol ; 6(7): 439-448, 2017 07.

Article in En | MEDLINE | ID: mdl-28556506

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Phenanthrenes / Organophosphates / Arthritis, Rheumatoid / Prednisone / Receptors, Glucocorticoid / Osteocalcin / Procollagen / Anti-Inflammatory Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2017 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google